![Roche Holding AG Logo](https://ik.imagekit.io/kkbzr2uz4cp/stock/six/rog.png?tr=w-200)
Roche Holding AG
SIX:ROG
![Roche Holding AG Logo](https://ik.imagekit.io/kkbzr2uz4cp/stock/six/rog.png)
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Realty Income Corp
NYSE:O
|
Real Estate
|
US |
![]() |
Walt Disney Co
NYSE:DIS
|
Media
|
US |
![]() |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
214.1
285.7
|
Price Target |
|
We'll email you a reminder when the closing price reaches CHF.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
Abbvie Inc
NYSE:ABBV
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
3M Co
NYSE:MMM
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Realty Income Corp
NYSE:O
|
US |
![]() |
Walt Disney Co
NYSE:DIS
|
US |
![]() |
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
![](https://ik.imagekit.io/kkbzr2uz4cp/stock/six/rog.png)
Intrinsic Value
Roche Holding AG operates as a research healthcare company. [ Read More ]
The intrinsic value of one
ROG
stock under the Base Case scenario is
349.7
CHF.
Compared to the current market price of 285.7 CHF,
Roche Holding AG
is
Undervalued by 18%.
![](https://ik.imagekit.io/kkbzr2uz4cp/stock/six/rog.png?tr=w-200)
Valuation Backtest
Roche Holding AG
Run backtest to discover the historical profit from buying and selling
ROG
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Roche Holding AG
Current Assets | 33.4B |
Cash & Short-Term Investments | 10.5B |
Receivables | 11.4B |
Other Current Assets | 11.6B |
Non-Current Assets | 57B |
PP&E | 22.9B |
Intangibles | 24.2B |
Other Non-Current Assets | 9.9B |
Current Liabilities | 24.8B |
Accounts Payable | 4.3B |
Short-Term Debt | 1.4B |
Other Current Liabilities | 19.1B |
Non-Current Liabilities | 36.3B |
Long-Term Debt | 24.8B |
Other Non-Current Liabilities | 11.5B |
Earnings Waterfall
Roche Holding AG
Revenue
|
58.7B
CHF
|
Cost of Revenue
|
-15.6B
CHF
|
Gross Profit
|
43.1B
CHF
|
Operating Expenses
|
-24.6B
CHF
|
Operating Income
|
18.5B
CHF
|
Other Expenses
|
-7B
CHF
|
Net Income
|
11.5B
CHF
|
Free Cash Flow Analysis
Roche Holding AG
CHF | |
Free Cash Flow | CHF |
ROG Profitability Score
Profitability Due Diligence
Roche Holding AG's profitability score is 71/100. The higher the profitability score, the more profitable the company is.
![](https://ik.imagekit.io/kkbzr2uz4cp/stock/six/rog.png)
Score
Roche Holding AG's profitability score is 71/100. The higher the profitability score, the more profitable the company is.
ROG Solvency Score
Solvency Due Diligence
Roche Holding AG's solvency score is 68/100. The higher the solvency score, the more solvent the company is.
![](https://ik.imagekit.io/kkbzr2uz4cp/stock/six/rog.png)
Score
Roche Holding AG's solvency score is 68/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
ROG Price Targets Summary
Roche Holding AG
According to Wall Street analysts, the average 1-year price target for
ROG
is 277.6 CHF
with a low forecast of 217.15 CHF and a high forecast of 449.4 CHF.
Price Appreciation
ROG Price
Roche Holding AG
Average Annual Return | 6.18% |
Standard Deviation of Annual Returns | 20.54% |
Max Drawdown | -45% |
Market Capitalization | 227.8B CHF |
Shares Outstanding | 804 000 000 |
Percentage of Shares Shorted |
N/A
|
ROG News
Last Important Events
Roche Holding AG
Significant happenings or occurrences that are of interest to investors. These could be company-specific developments or market-wide shifts.
Sentiment Analysis
Roche Holding AG
Company Profile
![Roche Holding AG Logo](https://ik.imagekit.io/kkbzr2uz4cp/stock/six/rog.png?tr=w-200)
![Roche Holding AG Logo](https://ik.imagekit.io/kkbzr2uz4cp/stock/six/rog.png?tr=w-200)
Country
Industry
Market Cap
Dividend Yield
Description
Roche Holding AG operates as a research healthcare company. The company is headquartered in Basel, Basel-Stadt and currently employs 100,920 full-time employees. The company went IPO on 2001-05-04. The firm's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The firm develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The firm offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Contact
IPO
Employees
Officers
The intrinsic value of one
ROG
stock under the Base Case scenario is
349.7
CHF.
Compared to the current market price of 285.7 CHF,
Roche Holding AG
is
Undervalued by 18%.